| Just because a model catalyst effectively drives a reaction in a well-controlled environment doesn’t mean it will work as well under more practical conditions. For years, scientists have strived to predict catalysts’ performance. In an ultrahigh vacuum model reactor, catalysts typically work at lower pressures and temperatures than in applied catalytic reactor studies. | |
| Now, a team devised a way to bridge the gap between these two extremes. Using their approach, they can predict catalyst performance across a wider range of temperatures and pressures (Nature Catalysis, “Crossing the great divide between single-crystal reactivity and actual catalyst selectivity with pressure transients”). | |
| The findings show that scientists can use fundamental surface science to predict behavior in applied catalytic reactor studies. The study is a stepping stone in designing efficient catalytic processes. Further, this work offers in-depth insight into a series of reactions that turn alcohols to higher-value chemicals. |
Image Credit: Ryan Chen, Lawrence Livermore National Laboratory
News This Week
Oxford firm to screen 15,000 drugs in search for coronavirus cure
An Oxford-based firm that uses artificial intelligence to develop new medicines has teamed up with a UK national science facility to screen more than 15,000 drugs for their effectiveness as a treatment for Covid-19. [...]
New study sheds light on coronavirus infection mechanism
New research has shed light on a crucial biological mechanism that may have helped the coronavirus to infect humans and spread rapidly around the world. A detailed analysis of the virus’s structure shows that [...]
Comparing the coronavirus pandemic to past pathogenic threats: HIV, anthrax and Ebola
How does the COVID-19 pandemic compare to other infamous viral infections that have plagued us in modern times? It’s a question that’s been asked repeatedly in social media circles in recent weeks as people [...]
Nanoparticles could help us get closer to a treatment for COVID-19
There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, researchers have been racing to [...]
Corona Virus (COVID 19) Interview with Michael Osterholm an expert in infectious disease epidemiology.
Michael Osterholm is an internationally recognized expert in infectious disease epidemiology. He is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy [...]
Experts envision two scenarios if the new coronavirus isn’t contained
With the new coronavirus spreading from person to person (possibly including from people without symptoms), reaching four continents, and traveling faster than SARS, driving it out of existence is looking increasingly unlikely. It’s still [...]
Neural cells speed up function in 3D bioprinted skeletal muscle constructs
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have improved upon the 3D bioprinting technique they developed to engineer skeletal muscle as a potential therapy for replacing diseased or damaged muscle tissue, moving another [...]
Scientists Use a “Synaptor” to Link a Rat Neuron and a Silicon Neuron
An international team of scientists from the University of Southampton, the University of Padova, and the University of Zurich has connected a silicon neuron to a neuron from the rat hippocampus with an artificial [...]
The Ins & Outs of Gene Therapy Drug Development: an interview with NMIN’s Scientific Director
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of [...]
Powerful antibiotic discovered using machine learning for first time
A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world has been discovered using artificial intelligence. The drug works in a different way to existing antibacterials and is the [...]
“Bigger than DNA” — how AI is transforming the pharma industry
Artificial intelligence hit a big milestone in January — the first drug designed entirely using artificial intelligence entered human clinical trials. The compound, created by Oxford-based biotech company Exscientia, is aimed at treating obsessive-compulsive [...]
Achilles’ heel of ALL viruses? Scientists discover holy grail which could lead to UNIVERSAL vaccine
Researchers at the Massachusetts General Hospital (MGH) in the US have uncovered the ‘Achilles’ heel’ of most viruses which plague mankind, and could soon develop a universal vaccine. Vaccine research, development and testing takes [...]
Small world: atom-scale materials are the next tech frontier
Every age in the history of human civilisation has a signature material, from the Stone Age, to the Bronze and Iron Ages. We might even call today’s information-driven society the Silicon Age. Since the [...]
Human textiles to repair blood vessels
What if we could replace a patient's damaged blood vessels with brand new ones produced in a laboratory? This is the challenge set by Inserm researcher Nicolas L'Heureux, who is working on the human [...]
CRISPR cancer trial finds that gene-edited immune cells are safe
CRISPR gene-edited immune cells have been injected into three people with advanced cancer without any serious side effects, the first trial of its kind in the US. It is also the first CRISPR cancer [...]
Updated – Worldwide Press for “Human Brain/Cloud Interface”
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - February 9 2020 Since [...]
